What are the most common GLP-1 side effects?

Gastrointestinal effects dominate: nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite. They're usually worst early and after each dose increase, and tend to ease over time — which is exactly why the drugs start low and step up slowly.

How do I reduce nausea on a GLP-1?

Common clinician advice includes eating smaller, blander, lower-fat meals, stopping when full, staying hydrated, and not rushing dose increases. If nausea is severe or you can't keep fluids down, contact your prescriber — don't just push through it. This is general information, not medical advice.

What are the serious risks I should know about?

The FDA labels carry a boxed warning about thyroid C-cell tumors (and contraindicate the drugs if you or family have had medullary thyroid cancer or MEN 2), plus warnings for pancreatitis, gallbladder disease, low blood sugar (with insulin/sulfonylureas), acute kidney injury from dehydration, serious allergic reactions, and — because they slow stomach emptying — a risk of aspiration under anesthesia. Tell any surgeon or anesthesiologist that you take a GLP-1.

Do all GLP-1 drugs have the same side effects?

Broadly yes — they share a mechanism, so the GI effects and boxed warning apply across the class (including the dual GIP/GLP-1 drug tirzepatide). Some warnings are drug-specific, like diabetic retinopathy monitoring with semaglutide. Always read your specific product's Medication Guide.

GLP-1 side effects: what to expect, and what to watch for

The side effects shared by the GLP-1 drugs — Ozempic, Wegovy, Zepbound, Mounjaro, Rybelsus, Trulicity and the rest — straight from their FDA labels. Most are gastrointestinal and ease over time; a few are serious and worth knowing.

By the pharmaranks editorial teamReviewed against FDA prescribing information (DailyMed) sourcesHow we research

Common side effects

The most frequently reported effects (in the FDA labels, generally ≥5% of patients). They tend to be worst when starting and after each dose increase, then settle.

Nausea
Vomiting
Diarrhea
Constipation
Abdominal (stomach) pain
Decreased appetite
Injection-site reactions (for the injectables)

Serious warnings

Less common but important — from the labels’ boxed warning and Warnings & Precautions. This isn’t the complete list; read your product’s Medication Guide.

Thyroid C-cell tumors (Boxed Warning): These drugs carry the FDA's strongest (boxed) warning: they caused thyroid C-cell tumors in rodents; the human risk is unknown. They are contraindicated if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2). Report a neck lump, hoarseness, or trouble swallowing.
Pancreatitis: Inflammation of the pancreas has been reported. Seek care for severe, persistent stomach pain (which may radiate to the back), with or without vomiting.
Gallbladder disease: Gallstones and gallbladder inflammation can occur, especially with rapid weight loss. Tell your clinician about upper-right abdominal pain, fever, or yellowing of the skin/eyes.
Low blood sugar (hypoglycemia): Risk rises when combined with insulin or a sulfonylurea; your clinician may lower those doses. Know the symptoms (shakiness, sweating, confusion).
Acute kidney injury: Dehydration from severe nausea, vomiting, or diarrhea can harm the kidneys. Stay hydrated and report severe GI symptoms.
Pulmonary aspiration during anesthesia: Because these drugs slow stomach emptying, food may remain in the stomach longer — a 2024–2025 label warning. Tell any surgeon, anesthesiologist, or dentist that you take a GLP-1 before a procedure with sedation.
Diabetic retinopathy (semaglutide): Worsening of diabetic eye disease was reported in a semaglutide trial. People with a history of diabetic retinopathy should be monitored.
Serious allergic reactions: Anaphylaxis and angioedema have been reported. Get emergency care for swelling of the face/lips/throat or trouble breathing.

When to seek care

Get medical help for severe or persistent stomach pain (possible pancreatitis or gallbladder disease), signs of an allergic reaction (swelling of the face/throat, trouble breathing), symptoms of dehydration you can’t manage, or a neck lump/hoarseness. And tell any surgeon, anesthesiologist, or dentist that you take a GLP-1 before a procedure with sedation.

Ozempic & thyroid cancer: what the evidence says →GLP-1 dosing schedules →Compare the GLP-1 drugs →Supplements to support GLP-1s →

FAQ

What are the most common GLP-1 side effects?: Gastrointestinal effects dominate: nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite. They're usually worst early and after each dose increase, and tend to ease over time — which is exactly why the drugs start low and step up slowly.
How do I reduce nausea on a GLP-1?: Common clinician advice includes eating smaller, blander, lower-fat meals, stopping when full, staying hydrated, and not rushing dose increases. If nausea is severe or you can't keep fluids down, contact your prescriber — don't just push through it. This is general information, not medical advice.
What are the serious risks I should know about?: The FDA labels carry a boxed warning about thyroid C-cell tumors (and contraindicate the drugs if you or family have had medullary thyroid cancer or MEN 2), plus warnings for pancreatitis, gallbladder disease, low blood sugar (with insulin/sulfonylureas), acute kidney injury from dehydration, serious allergic reactions, and — because they slow stomach emptying — a risk of aspiration under anesthesia. Tell any surgeon or anesthesiologist that you take a GLP-1.
Do all GLP-1 drugs have the same side effects?: Broadly yes — they share a mechanism, so the GI effects and boxed warning apply across the class (including the dual GIP/GLP-1 drug tirzepatide). Some warnings are drug-specific, like diabetic retinopathy monitoring with semaglutide. Always read your specific product's Medication Guide.

Sources

General reference, not medical advice, and not a complete list of side effects. Report side effects to your clinician and to FDA MedWatch (1-800-FDA-1088). If you take or are considering a GLP-1, talk to a licensed clinician or pharmacist and read the product’s Medication Guide.